Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer.
Evelyn WaughJuan GlinkaDaniel A BreadnerRachel Q Liu HennesseyEphraim S TangLaura AllenStephen WelchKen LeslieAnton SkaroPublished in: Annals of hepato-biliary-pancreatic surgery (2024)
We found a survival benefit of NAC with FOLFIRINOX for BRPC. Greater pre-treatment of CA19-9 and multivessel involvement on initial imaging were associated with progression of the disease following NAC.
Keyphrases
- locally advanced
- rectal cancer
- transcription factor
- squamous cell carcinoma
- radiation therapy
- high resolution
- percutaneous coronary intervention
- lymph node
- genome wide analysis
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- coronary artery disease
- photodynamic therapy
- replacement therapy